OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Treatment of overdose in the synthetic opioid era
Phil Skolnick
Pharmacology & Therapeutics (2021) Vol. 233, pp. 108019-108019
Open Access | Times Cited: 82
Phil Skolnick
Pharmacology & Therapeutics (2021) Vol. 233, pp. 108019-108019
Open Access | Times Cited: 82
Showing 1-25 of 82 citing articles:
Overdose mortality rates for opioids and stimulant drugs are substantially higher in men than in women: state-level analysis
Eduardo R. Butelman, Yuefeng Huang, David H. Epstein, et al.
Neuropsychopharmacology (2023) Vol. 48, Iss. 11, pp. 1639-1647
Open Access | Times Cited: 41
Eduardo R. Butelman, Yuefeng Huang, David H. Epstein, et al.
Neuropsychopharmacology (2023) Vol. 48, Iss. 11, pp. 1639-1647
Open Access | Times Cited: 41
Clinical toxicity of nitazene detections in two Australian emergency department toxicosurveillance systems
Katherine Isoardi, Sam Alfred, Courtney Weber, et al.
Drug and Alcohol Review (2025)
Open Access | Times Cited: 2
Katherine Isoardi, Sam Alfred, Courtney Weber, et al.
Drug and Alcohol Review (2025)
Open Access | Times Cited: 2
Opioid use and abuse in adolescents and young adults; dealing with science, laws and ethics: Charming the COBRAS
Donald E. Greydanus, Ahsan Nazeer, Dilip R. Patel
Disease-a-Month (2025), pp. 101853-101853
Closed Access | Times Cited: 1
Donald E. Greydanus, Ahsan Nazeer, Dilip R. Patel
Disease-a-Month (2025), pp. 101853-101853
Closed Access | Times Cited: 1
Pharmacological Methods of Pain Management: Narrative Review of Medication Used
Nasser M. Alorfi
International Journal of General Medicine (2023) Vol. Volume 16, pp. 3247-3256
Open Access | Times Cited: 29
Nasser M. Alorfi
International Journal of General Medicine (2023) Vol. Volume 16, pp. 3247-3256
Open Access | Times Cited: 29
Old Drugs and New Challenges: A Narrative Review of Nitazenes
Joseph V. Pergolizzi, Robert B. Raffa, Jo Ann LeQuang, et al.
Cureus (2023)
Open Access | Times Cited: 28
Joseph V. Pergolizzi, Robert B. Raffa, Jo Ann LeQuang, et al.
Cureus (2023)
Open Access | Times Cited: 28
Pharmacological Support for the Treatment of Obesity—Present and Future
Marcin Kosmalski, Kacper Deska, Bartłomiej Bąk, et al.
Healthcare (2023) Vol. 11, Iss. 3, pp. 433-433
Open Access | Times Cited: 23
Marcin Kosmalski, Kacper Deska, Bartłomiej Bąk, et al.
Healthcare (2023) Vol. 11, Iss. 3, pp. 433-433
Open Access | Times Cited: 23
Fact vs. fiction: naloxone in the treatment of opioid-induced respiratory depression in the current era of synthetic opioids
Albert Dahan, Thomas S. Franko, James W. Carroll, et al.
Frontiers in Public Health (2024) Vol. 12
Open Access | Times Cited: 11
Albert Dahan, Thomas S. Franko, James W. Carroll, et al.
Frontiers in Public Health (2024) Vol. 12
Open Access | Times Cited: 11
Clinical Pharmacokinetics and Pharmacodynamics of Naloxone
Teijo I. Saari, John Strang, Ola Dale
Clinical Pharmacokinetics (2024) Vol. 63, Iss. 4, pp. 397-422
Open Access | Times Cited: 11
Teijo I. Saari, John Strang, Ola Dale
Clinical Pharmacokinetics (2024) Vol. 63, Iss. 4, pp. 397-422
Open Access | Times Cited: 11
Pharmacologic Characterization of Substituted Nitazenes atμ,κ, andΔOpioid Receptors Suggests High Potential for Toxicity
Laura B. Kozell, Amy J. Eshleman, Katherine M. Wolfrum, et al.
Journal of Pharmacology and Experimental Therapeutics (2024) Vol. 389, Iss. 2, pp. 219-228
Open Access | Times Cited: 7
Laura B. Kozell, Amy J. Eshleman, Katherine M. Wolfrum, et al.
Journal of Pharmacology and Experimental Therapeutics (2024) Vol. 389, Iss. 2, pp. 219-228
Open Access | Times Cited: 7
Intoxications in an Australian Emergency Department Involving ‘Nitazene’ Benzylbenzimidazole Synthetic Opioids (Etodesnitazene, Butonitazene and Protonitazene)
Jennifer Schumann, Rebekka Syrjanen, Katherine Alford, et al.
Journal of Analytical Toxicology (2022) Vol. 47, Iss. 1, pp. e6-e9
Closed Access | Times Cited: 33
Jennifer Schumann, Rebekka Syrjanen, Katherine Alford, et al.
Journal of Analytical Toxicology (2022) Vol. 47, Iss. 1, pp. e6-e9
Closed Access | Times Cited: 33
New Synthetic Opioids: Clinical Considerations and Dangers
Amber N. Edinoff, David Martinez Garza, Stephen P. Vining, et al.
Pain and Therapy (2023) Vol. 12, Iss. 2, pp. 399-421
Open Access | Times Cited: 20
Amber N. Edinoff, David Martinez Garza, Stephen P. Vining, et al.
Pain and Therapy (2023) Vol. 12, Iss. 2, pp. 399-421
Open Access | Times Cited: 20
Stronger, longer, better opioid antagonists? Nalmefene is NOT a naloxone replacement
Alexander F. Infante, Abigail T. Elmes, Renee Petzel Gimbar, et al.
International Journal of Drug Policy (2024) Vol. 124, pp. 104323-104323
Open Access | Times Cited: 6
Alexander F. Infante, Abigail T. Elmes, Renee Petzel Gimbar, et al.
International Journal of Drug Policy (2024) Vol. 124, pp. 104323-104323
Open Access | Times Cited: 6
Brain oxygen responses induced by opioids: focus on heroin, fentanyl, and their adulterants
Eugene A. Kiyatkin, Shinbe Choi
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 6
Eugene A. Kiyatkin, Shinbe Choi
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 6
Reversal of Opioid‐Induced Respiratory Depression in Healthy Volunteers: Comparison of Intranasal Nalmefene and Intranasal Naloxone
Mark J. Ellison, Emily Hutton, Lynn R. Webster, et al.
The Journal of Clinical Pharmacology (2024) Vol. 64, Iss. 7, pp. 828-839
Open Access | Times Cited: 6
Mark J. Ellison, Emily Hutton, Lynn R. Webster, et al.
The Journal of Clinical Pharmacology (2024) Vol. 64, Iss. 7, pp. 828-839
Open Access | Times Cited: 6
High-dose naloxone formulations are not as essential as we thought
Paige M. Lemen, Daniel P. Garrett, Erin Thompson, et al.
Harm Reduction Journal (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 6
Paige M. Lemen, Daniel P. Garrett, Erin Thompson, et al.
Harm Reduction Journal (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 6
LCMS Detection and Characterization of In Vitro Metabolites of Isotonitazene, a Targeted Strategy for Novel Psychoactive Substance Control in Camel Racing
Jahfar Nalakath, Rasik Puzhithinipra Rasik, Ahmed Kadry, et al.
Rapid Communications in Mass Spectrometry (2025) Vol. 39, Iss. 7
Closed Access
Jahfar Nalakath, Rasik Puzhithinipra Rasik, Ahmed Kadry, et al.
Rapid Communications in Mass Spectrometry (2025) Vol. 39, Iss. 7
Closed Access
The Rise of Fentanyl: Molecular Aspects and Forensic Investigations
C Barletta, Vincenzo Natale, Massimiliano Esposito, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 444-444
Open Access
C Barletta, Vincenzo Natale, Massimiliano Esposito, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 444-444
Open Access
Impact of Fentanyl Test Strips as Harm Reduction for Drug-Related Mortality
Moiz Bhai, Benjamin J. McMichael, David Mitchell
Medical Care Research and Review (2025)
Closed Access
Moiz Bhai, Benjamin J. McMichael, David Mitchell
Medical Care Research and Review (2025)
Closed Access
Physical and chemical criteria for hazard assessment of CNS-active xenobiotics
Д. В. Криворотов, Anatolii Ivanovich Nikolaev, А. С. Радилов, et al.
(2025)
Closed Access
Д. В. Криворотов, Anatolii Ivanovich Nikolaev, А. С. Радилов, et al.
(2025)
Closed Access
Risk of Delayed Intubation After Presumed Opioid Overdose in the Emergency Department
Daniel McCabe, Heath Gibbs, Alessandra Pratt, et al.
Annals of Emergency Medicine (2025)
Closed Access
Daniel McCabe, Heath Gibbs, Alessandra Pratt, et al.
Annals of Emergency Medicine (2025)
Closed Access
Developing predictive models for µ opioid receptor binding using machine learning and deep learning techniques
Jie Liu, Vassilia Michailidis, Zoe Li, et al.
Experimental Biology and Medicine (2025) Vol. 250
Open Access
Jie Liu, Vassilia Michailidis, Zoe Li, et al.
Experimental Biology and Medicine (2025) Vol. 250
Open Access
Discriminative stimulus and antinociceptive effects of sixteen nitazene analogs in rodents
Michael B. Gatch, Rebecca Hill, Megana Sundar, et al.
Neuropharmacology (2025), pp. 110416-110416
Closed Access
Michael B. Gatch, Rebecca Hill, Megana Sundar, et al.
Neuropharmacology (2025), pp. 110416-110416
Closed Access
Non-fentanyl new synthetic opioids – An update
Jolanta B. Zawilska, Piotr Adamowicz, Marta Kurpeta, et al.
Forensic Science International (2023) Vol. 349, pp. 111775-111775
Closed Access | Times Cited: 14
Jolanta B. Zawilska, Piotr Adamowicz, Marta Kurpeta, et al.
Forensic Science International (2023) Vol. 349, pp. 111775-111775
Closed Access | Times Cited: 14
Total-body imaging of mu-opioid receptors with [11C]carfentanil in non-human primates
Chia‐Ju Hsieh, Catherine Hou, Hsiaoju Lee, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2024) Vol. 51, Iss. 11, pp. 3273-3283
Open Access | Times Cited: 4
Chia‐Ju Hsieh, Catherine Hou, Hsiaoju Lee, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2024) Vol. 51, Iss. 11, pp. 3273-3283
Open Access | Times Cited: 4
Naloxone’s dose-dependent displacement of [11C]carfentanil and duration of receptor occupancy in the rat brain
Yeona Kang, Kelly A. O’Conor, Andrew Kelleher, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 19
Yeona Kang, Kelly A. O’Conor, Andrew Kelleher, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 19
